Tsukasa Baba Selected Research

Tsukasa Baba Research Topics

Disease

66	Neoplasms (Cancer) 11/2023 - 03/2006
38	Ovarian Neoplasms (Ovarian Cancer) 09/2023 - 06/2007
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023 - 05/2014
12	Endometrial Neoplasms (Endometrial Cancer) 01/2024 - 03/2011
11	Carcinoma (Carcinomatosis) 11/2023 - 12/2010
8	Neoplasm Metastasis (Metastasis) 09/2020 - 01/2010
6	Carcinosarcoma 09/2018 - 01/2017
5	Ovarian Epithelial Carcinoma 09/2023 - 02/2009
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2023 - 05/2014
4	Carcinogenesis 06/2015 - 03/2006
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2021 - 01/2010
3	Hypoxia (Hypoxemia) 01/2020 - 01/2013
3	Sarcoma (Soft Tissue Sarcoma) 09/2018 - 01/2017
2	Hypertension (High Blood Pressure) 03/2023 - 12/2022
2	Anemia 03/2023 - 01/2014
2	Proteinuria 03/2023 - 12/2022
2	Thrombocytopenia (Thrombopenia) 03/2023 - 04/2016
2	Endometrial Hyperplasia 01/2023 - 06/2015
2	Vulvar Neoplasms (Vulvar Cancer) 05/2021 - 11/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2020 - 01/2014
2	Postpartum Depression (Post-Natal Depression) 01/2020 - 09/2019
2	Colorectal Neoplasms (Colorectal Cancer) 09/2019 - 02/2011
2	Pre-Eclampsia (Preeclampsia) 01/2019 - 01/2018
2	Vomiting 02/2017 - 04/2016
2	Endometrioid Carcinoma 02/2015 - 12/2003
2	Adenocarcinoma 03/2011 - 12/2003
1	Prostatic Neoplasms (Prostate Cancer) 12/2023
1	Constipation 03/2023
1	Neutropenia 03/2023
1	Leukopenia 03/2023
1	Hypersensitivity (Allergy) 03/2023
1	Intestinal Perforation 12/2022
1	Endometriosis 11/2021
1	Uterine Neoplasms (Uterine Cancer) 05/2021
1	Herpes Simplex 03/2021

Drug/Important Bio-Agent (IBA)

20	PlatinumIBA 09/2023 - 12/2003
9	Biomarkers (Surrogate Marker)IBA 09/2023 - 08/2007
9	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 08/2007
8	LigandsIBA 01/2021 - 05/2009
4	taxaneIBA 12/2023 - 02/2009
4	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 02/2009
4	Carboplatin (JM8)FDA LinkGeneric 03/2023 - 04/2016
4	Bevacizumab (Avastin)FDA Link 03/2023 - 09/2019
4	NivolumabIBA 01/2021 - 12/2015
4	Proteins (Proteins, Gene)FDA Link 05/2018 - 02/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2017 - 05/2010
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 03/2023
3	Immune Checkpoint InhibitorsIBA 01/2023 - 06/2016
3	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 08/2020 - 10/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 06/2007
3	B7-H1 AntigenIBA 01/2016 - 03/2013
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2015 - 01/2011
2	olaparibIBA 12/2023 - 05/2021
2	7-hydroxystaurosporine (UCN 01)IBA 01/2021 - 05/2010
2	ChemokinesIBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 08/2020 - 06/2015
2	Angiogenesis InhibitorsIBA 03/2020 - 09/2019
2	Tuberculin (PPD)IBA 01/2020 - 09/2019
2	Progesterone FDA LinkGeneric 01/2019 - 06/2015
2	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2015
2	AntibodiesIBA 01/2017 - 06/2016
2	Transcription Factors (Transcription Factor)IBA 10/2015 - 12/2010
2	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 01/2015
2	KisspeptinsIBA 06/2015 - 04/2011
2	Sorafenib (BAY 43-9006)FDA Link 01/2014 - 12/2010
2	Messenger RNA (mRNA)IBA 01/2013 - 02/2009
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2012 - 12/2011
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2011 - 03/2009
2	Taxoids (Taxanes)IBA 02/2009 - 12/2003
1	lenvatinibIBA 01/2024
1	pembrolizumabIBA 01/2024
1	Androgen Receptors (Androgen Receptor)IBA 12/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023
1	Progestins (Progestagens)IBA 01/2023
1	niraparibIBA 05/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2021
1	Coloring Agents (Dyes)IBA 05/2021
1	Radioisotopes (Radionuclides)IBA 05/2021
1	Protein Kinase CIBA 01/2021
1	oltiprazIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2020
1	Sunitinib (Sutent)FDA Link 09/2020
1	Uridine Diphosphate (UDP)IBA 08/2020

Therapy/Procedure

26	Therapeutics 10/2023 - 12/2003
24	Drug Therapy (Chemotherapy) 12/2023 - 02/2009
14	Hysterectomy 10/2023 - 01/2010
6	Radiotherapy 11/2023 - 04/2016
6	Adjuvant Chemotherapy 10/2023 - 03/2012
6	Immunotherapy 01/2022 - 01/2010
5	Neoadjuvant Therapy 03/2018 - 05/2014
4	Salpingo-oophorectomy 03/2020 - 11/2013
4	Lymph Node Excision (Lymph Node Dissection) 11/2018 - 01/2014
3	Minimally Invasive Surgical Procedures 11/2023 - 11/2016
3	Laparotomy 01/2021 - 06/2015
2	Chemoradiotherapy 05/2021 - 04/2016
1	Aftercare (After-Treatment) 01/2024
1	Castration 12/2023
1	Oncolytic Virotherapy 01/2023
1	Nephrectomy 09/2020